LXRX

Lexicon Pharmaceuticals Stock Price

1.95
-0.01 (-0.51%)
Upgrade to Real-Time
Regular Market
1.95
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.01 -0.51% 1.95 1.91 1.96 1.92 1.96 09:33:55
Bid Price Ask Price Spread Spread % News
1.95 1.96 0.01 0.51% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
160 29,972 $ 1.92 $ 57,644 2,514,168 1.16 - 6.19
Last Trade Time Type Quantity Stock Price Currency
09:34:06 6 $ 1.96 USD

Lexicon Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 205.65M 107.11M 28.90M $ 322.07M $ 110.05M 1.09 3.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Lexicon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.752.731.701.955,012,8600.2011.43%
1 Month1.914.131.701.973,297,1960.042.09%
3 Months2.014.131.701.971,752,704-0.06-2.99%
6 Months3.224.131.652.091,321,017-1.27-39.44%
1 Year1.256.191.162.771,506,6290.7056.0%
3 Years15.7815.821.1255.32970,597-13.83-87.64%
5 Years12.8419.621.1258.30878,323-10.89-84.81%

Lexicon Pharmaceuticals Description

Lexicon Pharmaceuticals Inc is a biopharmaceutical company developing medicines that transform patients' lives. The company commercializes and develops drugs and drug candidates. Its drugs candidates include XERMELO (telotristat ethyl), an orally-delivered small molecule drug, in the United States for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog, or SSA, therapy in adults inadequately controlled by SSA therapy; Zynquista (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 diabetes; sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease; and LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.